2021 Pharmaceutical Value chain 
Frost & Sullivan Manufacturing
DECEMBER 25, 2024
Aligning with Industry Trends: Healthnice Advances Step by Step Amid the global pharmaceutical industry’s evolution, high-end preparations have become a mainstream trend in drug development. Low-value drugs with significant product homogeneity face a higher risk of market elimination.
Frost & Sullivan Manufacturing
JUNE 16, 2022
June 16, 2022- Frost & Sullivan’s recent analysis, Global Pharmaceuticals Outlook , finds that the accelerated drug development timelines are driving digitalization and innovation across the pharmaceutical value chain. trillion in 2021 under the aspirational scenario. Global Pharmaceuticals Outlook, 2022.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Robotics Business Review
JANUARY 26, 2024
. “By teaming with Mujin, a leader in robotics technology, Accenture will be able to help our clients take advantage of AI and robotics to connect data throughout the manufacturing and logistics value chain, further contributing to the data-driven transformation of Japan’s important manufacturing and logistics industries.”
Frost & Sullivan Manufacturing
AUGUST 30, 2022
As many companies globally commit to net-zero and science-based targets, the industry’s focus is gradually shifting from responsible sourcing, onsite recycling, and alternative energy solutions to tackling emission reduction across the value chain. direct emissions from a company’s facilities and vehicles) and scope 2 (i.e.,
Additive Manufacturing
JANUARY 5, 2023
Value Chain: Sigma Additive Solutions and Dyndrite Announce Agreement to Build Connected In-process Data Software Using Dyndrite Application Development Kit : Sigma Additive Solutions , Inc. ProtoCAM will merge into Midwest Prototyping, Prototek’s additive manufacturing arm acquired in July 2021. and Siemens Ltd.,
Expert insights. Personalized for you.
52 
Let's personalize your content